In addition, in human NSCLC cell lines, ADAM17 can upregulate EGFR expression via Notch1, thus modulating cell responsiveness to EGFR ligands (Baumgart et al, 2010). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.